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A B S T R A C T
Pallister Killian syndrome (PKS) is a rare genetic disorder caused by tetrasomy of the short arm of chromosome 12,
revealed usually in mosaic distribution of an extra i(12)(p10) chromosome in fibroblasts. The syndrome presents with a
recognizable pattern of findings including pigmentary skin changes, coarse face, high forehead, sparse anterior scalp
hair, hypertelorism, seizures and progressive psychomotor developmental delay. It was first described independently by
Pallister in 1977 and by Killian and Teschler-Nikola in 19811,2. We report a case of 21 month old girl with PKS and sig-
nificant overgrowth. Cytogenetic analysis was performed using the GTG banding technique. The karyotype of cultured
lymphocytes was normal. The karyotype from skin fibroblasts was established as mosaic tetrasomy of 12p 47,XX,+i(12)
(p10)/46,XX. The origin of the extra marker chromosome was determinated by fluorescence in situ hybridization with
chromosome 12 specific DNA probes confirming that supernumerary marker is chromosome i(12p) in 68% of cells. De-
spite the excessive postnatal growth we found low serum growth hormone levels and reduced response to pharmacologi-
cal stimulation test. This is also the first report of a postnatal patient in our country.
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Introduction
Pallister-Killian syndrome is a dysmorphic condition
involving most organ systems, but also characterized by
a tissue-limited mosaicism; most fibroblasts have 47 chro-
mosomes with an extra small metacentric chromosome,
whereas the karyotype of lymphocytes is normal. The ex-
tra metacentric chromosome is an isochromosome for
part of the short arm of chromosome 12: i(12)(p10). The
syndrome was first described independently by Pallister
in 1977 and by Killian and Teschler-Nikola in 19811,2. It
presents with a recognizable pattern of findings includ-
ing pigmentary skin changes, mental retardation, con-
genital hypotonia, seizures and facial anomalies, such as
hypertelorism, coarse face, broad high forehead, sparse
eyebrows and eyelashes, abnormal ears, macrostomia,
short nose with anteverted nostrils, broad nasal bridge,
sparse anterior scalp hair, short neck. Hearing deficit,
congenital heart defects, accessory nipples, distal digital
hypoplasia, diaphragmatic hernia, anal and genito – uri-
nary abnormalities are also present. Growth pattern in
these children is characterized by normal to increased
birth length with postnatal deceleration of length, nor-
mal to increased birth weight with postnatal obesity, and
normal to increased head circumference at birth, with
postnatal deceleration of its growth3–5. Some newborns
were reported as unusually large. The cause for macro-
somia is unknown. Syndrome has very low recurrence
risk, all described cases were sporadic.
We report a case of 21 month old girl with PKS and
significant postnatal overgrowth. The karyotype from
skin fibroblasts was established as mosaic tetrasomy of
12p 47,XX,+i(12)(p10)/46,XX. The origin of the extra
marker chromosome was confirmed by fluorescence in
situ hybridization, consistent with Pallister-Killian syn-
drome. Despite of excessive postnatal growth we found
low serum GH levels and reduced response to pharmaco-
logical stimulation test. This is also the first report of
postnatal patient in our country.
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Clinical Report
The patient was born at term following normal preg-
nancy, by spontaneous vaginal delivery. The 40-year-old
father and 34-year-old mother are healthy and unre-
lated. Birth weight was 3150 g (25 to 50th centile), length
was 49 cm (25 to 50th centile) and head circumference 37
cm (75–90th centile). Apgars were 7 and 8. The child was
hypotonic with facial dysmorphy and relative macro-
crania. She had one episode of seizures in the second day
of life treated with phenobarbital, metabolic disturban-
ces such as hypoglycemia, hypocalcemia and hypomagne-
semia were excluded. Peripheral blood chromosome anal-
ysis performed in the first month of life in another
hospital showed normal karyotype. DNA analysis for
muscular dysthrophy was negative.
During the first months of life mother noticed several
areas of skin hypopigmentation. Due to delayed motor
milestones, physical therapy was started without signifi-
cant progress. After several acute middle ear infections
and suspected hearing loss, otorhinolaryngological eval-
uation was performed and sensory hearing loss was con-
firmed. Despite normal calorie intake child showed ex-
cessive postnatal growth (increased weight, length and
head circumference).
At the age of 21 months the patient was referred to
our Department for genetic reevaluation. At this time
she was overweight with 18.5 kg (+4.3 SD), with length
93 cm (+2.89 SD), head circumference 53 cm (+4.5 SD),
BMI 21.5 kg/m2. She had marked muscular hypotonia
and severely delayed psychomotor development (con-
stant position on back, severely reduced spontaneous
movements, did not follow objects in front of her, did not
sit by herself). Her face was coarse, with high forehead,
frontal bossing, hypertelorism, broad nasal bridge and
anteverted nostrils. Bilateral frontotemporal alopecia and
sparse eyebrows were also noticed. She had hypopig-
mented skin areas on forehead, in lumbal region and on
back side of thighs.
Because of overgrowth we evaluated growth hormone
(GH) levels with L dopa stimulation test and found low
serum GH levels and reduced response to pharmacologi-
cal stimulation test. Insulin-like growth factor (IGF-1)
and insulin-like growth factor binding protein 3 (IGF
BP3), insulin and glucose levels were normal.
Brain MRI, similar to previous reports6, showed pro-
minent atrophy of supratentorial parenchyma with fron-
tal and temporal predominance, dilatation of subarach-
noidal spaces, periventricular leucomalacia with volume
reduction of white mater and athrophy of corpus callo-
sum. Glandula pinealis was enlarged 10 mm in diame-
ther, inhomogenic, without signs of compression.
Visual evoked potentials showed impaired retino-
cortical conduction. Heart ultrasound showed tricus-
pidal valve insufficiency. Abdominal ultrasound was
normal.
Cytogenetic Studies
Methods
The chromosome analyses were performed on meta-
phases derived from peripheral blood and skin fibrobla-
sts. Skin biopsy was taken from pigmented and hypopig-
mented areas of her leg and set up in culture flasks for
long – term culture cytogenetic analysis. The fibroblasts
were fed in culture media following which the cells di-
vided and grew as a single layer attached to the culture
flask surface producing cell colonies. Cultures were har-
vested when colonies were sufficient, 9–15 days after
seeding. The cells were removed from original culture
flasks following mitotic arrest with colchicine and treat-
ment with trypsin. When most of the cells were floating
freely, culture medium was added. The cells were then
centrifuged and media and mitotic inhibitor removed
and replaced with a hypotonic KCl solution. This caused
the cells to swell so that the chromosomes would spread
when added to a slide. After the cells have been allowed
to rest in hypotonic solution the fixative (3:1 methanol to
glacial acetic acid) was added, which ensured the removal
of cytoplasm and cell debris. The fixed cell suspension
was then dropped onto microscope slides. After aging the
slides were ready for banding and analysis. Routine chro-
mosome analysis refers to analysis of metaphase chromo-
somes which have been banded using trypsin followed by
Giemsa. G-banded chromosome studies were performed
from peripheral blood lymphocytes and skin fibroblast
cultures of the patient following standard protocols7.
Fluorescence in situ hybridization (FISH) techniques
were employed to identify the chromosomal origin of the
marker chromosomes. FISH study on metaphases and
interphases of peripheral blood lymphocytes and cul-
tured fibroblasts was performed according to standard
procedure. Centromere, whole paint probe 12 and locus
specific 12p13 probe were used (Q-biogene)8. Karyotypes
were described in accordance with the International Sys-
tem for Human Cytogenetic Nomenclature (ISCN) 20059.
Results
Chromosome analysis of patient´s peripheral blood
lymphocytes showed no evidence of chromosomally ab-
normal cells and revealed a normal karyotype. It was
confirmed by fluorescence in situ hybridization using a
12 centromeric probe.
S. Huljev Frkovi} et al.: Case Report of Pallister Killian Syndrome, Coll. Antropol. 34 (2010) 1: 247–250
248
Fig. 1. GTG-banded metaphase in cultured fibroblasts with iso-
chromosome 12p 47,XX,+i(12)(p10).
The marker chromosome was found in cultured fibro-
blasts from pigmented and hypopigmented skin biopsy.
Standard G-banding techniques revealed a mosaic kar-
yotype 47,XX,+i(12)(p10)/46,XX (Figure 1). Tetrasomy
for the short arm of chromosome 12 was documented in
19/30 of the cells from pigmented skin. In hypopigmen-
ted skin proportion was 22/35 of tetrasomy 12p (Figure
2). The chromosomal nature of marker chromosomes
was investigated by fluorescent in situ hybridization
with biotinylated or digoxigenin labelled probes: the chro-
mosome12 centromere probe, 12 whole-painting probe
(Figure 3) and locus specific 12p13 (TEL)/21q22 (AML1)
probe (Figure 4). It was confirmed that the supernumer-
ary marker was isochromosome 12p in 68% of cells. A
whole chromosome 12 painting probe stained the marker
chromosome completely. Our approach, using locus spe-
cific 12p13 probe showed four fluorescence-positive spots
and has high specificity and sensitivity for the diagnosis
of the real distribution of the isochromosome 12p in vari-
ous tissues.
Discussion
The Pallister Killian syndrome (PKS) is characterized
by tissue-limited mosaicism for tetrasomy 12p. All re-
ported cases of syndrome have occurred sporadically.
The incidence of metaphases containing i(12p) has
been reported to be 0% to 2% in lymphocytes, 50% to
100% in skin fibroblasts, and 100% in amniocytes10–12. In
some studies, the fibroblasts cultured from areas of al-
tered pigmentation are said to yield a higher incidence of
i(12p) metaphases13. In our case the presence of a super-
numerary metacentric chromosome i(12p) was confined
to skin fibroblasts while the karyotype of cultured lym-
phocytes was normal. Karyotyping of fibroblasts showed
the presence of an isochromosome 12p in around 65% of
the metaphases. In our study there was no difference of
marker chromosome frequency between pigmented and
hypopigmented areas of the skin.
A wide phenotypic variability has been reported rang-
ing from perinatal death due to multiple congenital ano-
malies to the classical phenotype including facial dysmor-
phism and severe mental retardation3,14. A correlation
between the percentage of 12p tetrasomic cells in skin
fibroblasts and the phenotypic severity is not striking4,15.
Our patient presented with most of the classical features
of the syndrome: severe mental retardation, hypotonia,
coarse facial appearance, broad forehead, bilateral fronto-
temporal alopecia, hypertelorism, skin pigmentary chan-
ges and hearing loss10,15,16.
Although prenatal and perinatal macrosomia were
previously observed, growth parameters of PKS patients
in further life are usually normal or a growth retardation
is observed. An interesting and unusual finding in our
patient is excessive postnatal growth with low growth
hormone levels and reduced response to L dopa stimula-
tion test. Possible explanation for overgrowth, similar to
other described unusual findings in other reported cases,
may be in the time of mosaic formation as well as somatic
selection of different intensity in different tissues at dif-
ferent times17. On the other hand, influence of genes
whose locus was assigned to 12p on overgrowth is not
clarified yet.
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Fig. 2. Partial karyogram of isochromosome 12p with idiograms.
Fig. 3. Fluorescence in situ hybridization with chromosome 12
centromere (red) and WCP12 (green) showed chromosome 12
and isochromosome 12p.
Fig. 4. Fluorescence in situ hybridization with locus specific
probe 12p13 showed four red fluorescence-positive spots (21q22,
green control signals).
Conclusions
Although tetrasomy 12p is the most frequent auto-
somal tetrasomy in humans, it is usually not detected
during routine cytogenetic analysis of peripheral blood
lymphocytes due to tissue-specific mosaicism, so many
cases have likely been diagnosed as unknown congenital
multiple anomaly syndrome. Clinical recognition is cru-
cial for the decision to perform appropriate cytogenetic
investigations from different tissues. In genetic counsel-
ing is important to emphasize the low recurrence risk.
To our knowledge, previous reported patients showed
normal growth parameters or growth retardation later in
life. We describe a case of excessive postnatal overgrowth
as a possible new feature of the syndrome.
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PALLISTER KILLIANOV SINDROM: NEOBI^AN POSTNATALNI PREKOMJERNI RAST U
DJEVOJ^ICE S INA^E TIPI^NOM KLINI^KOM PREZENTACIJOM
S A @ E T A K
Pallister Killian sindrom (PKS) je rijedak genetski poreme}aj uzrokovan tetrasomijom kratkog kraka kromosoma
12, koji se obi~no otkriva u mozai~koj raspodjeli prekobrojnog i(12)(p10) kromosoma u fibroblastima. Sindrom se pre-
zentira prepoznatljivim fenotipskim karakteristikama kao {to su pigmentirane ko`ne promjene, grube crte lica, visoko
~elo, rijetka kosa prednjeg dijela vlasi{ta, hipertelorizam, konvulzije, te progresivno psihomotorno zaostajanje. Prvi put
je opisan neovisno od strane Pallistera 1977. godine, te Killiana i Teschler-Nikole 1981. godine1,2. Prikazujemo slu~aj
dvadesetjedno mjese~ne djevoj~ice sa PKS-om i zna~ajnim prekomjernim rastom. Citogenetska analiza je u~injena kori-
{tenjem tehnike GTG pruganja. Kariotip kultiviranih limfocita je bio uredan. U kariotipu ko`nih fibroblasta je na|ena
je mozai~na tetrasomija 12p: 47,XX,+i(12)(p10)/46,XX. Porijeklo prekobrojnog marker kromosoma utvr|eno je fluore-
scentnom in situ hibridizacijom sa kromosom 12 specifi~nim DNA probama. Prekobrojni marker kromosom i(12p)
na|en je u 68% stanica. Usprkos ubrzanom postnatalnom rastu, utvrdili smo niske serumske razine hormona rasta uz
izostanak o~ekivanog odgovora tijekom farmakolo{kog testa stimulacije. Ovo je tako|er prikaz prvog ro|enog bolesnika
u na{oj zemlji.
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